Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Oct 1;100(7):1831–1839. doi: 10.1172/JCI119711

Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

L Rossetti 1, A E Stenbit 1, W Chen 1, M Hu 1, N Barzilai 1, E B Katz 1, M J Charron 1
PMCID: PMC508369  PMID: 9312184

Abstract

Glucose transporter type 4 (GLUT4) is insulin responsive and is expressed in striated muscle and adipose tissue. To investigate the impact of a partial deficiency in the level of GLUT4 on in vivo insulin action, we examined glucose disposal and hepatic glucose production (HGP) during hyperinsulinemic clamp studies in 4-5-mo-old conscious mice with one disrupted GLUT4 allele [GLUT4 (+/-)], compared with wild-type control mice [WT (+/+)]. GLUT4 (+/-) mice were studied before the onset of hyperglycemia and had normal plasma glucose levels and a 50% increase in the fasting (6 h) plasma insulin concentrations. GLUT4 protein in muscle was approximately 45% less in GLUT4 (+/-) than in WT (+/+). Euglycemic hyperinsulinemic clamp studies were performed in combination with [3-3H]glucose to measure the rate of appearance of glucose and HGP, with [U-14C]-2-deoxyglucose to estimate muscle glucose transport in vivo, and with [U-14C]lactate to assess hepatic glucose fluxes. During the clamp studies, the rates of glucose infusion, glucose disappearance, glycolysis, glycogen synthesis, and muscle glucose uptake were approximately 55% decreased in GLUT4 (+/-), compared with WT (+/+) mice. The decreased rate of in vivo glycogen synthesis was due to decreased stimulation of glucose transport since insulin's activation of muscle glycogen synthase was similar in GLUT4 (+/-) and in WT (+/+) mice. By contrast, the ability of hyperinsulinemia to inhibit HGP was unaffected in GLUT4 (+/-). The normal regulation of hepatic glucose metabolism in GLUT4 (+/-) mice was further supported by the similar intrahepatic distribution of liver glucose fluxes through glucose cycling, gluconeogenesis, and glycogenolysis. We conclude that the disruption of one allele of the GLUT4 gene leads to severe peripheral but not hepatic insulin resistance. Thus, varying levels of GLUT4 protein in striated muscle and adipose tissue can markedly alter whole body glucose disposal. These differences most likely account for the interindividual variations in peripheral insulin action.

Full Text

The Full Text of this article is available as a PDF (281.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ader M., Bergman R. N. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol. 1990 Jun;258(6 Pt 1):E1020–E1032. doi: 10.1152/ajpendo.1990.258.6.E1020. [DOI] [PubMed] [Google Scholar]
  2. Andersen P. H., Lund S., Vestergaard H., Junker S., Kahn B. B., Pedersen O. Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab. 1993 Jul;77(1):27–32. doi: 10.1210/jcem.77.1.8325952. [DOI] [PubMed] [Google Scholar]
  3. Bali D., Svetlanov A., Lee H. W., Fusco-DeMane D., Leiser M., Li B., Barzilai N., Surana M., Hou H., Fleischer N. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem. 1995 Sep 15;270(37):21464–21467. doi: 10.1074/jbc.270.37.21464. [DOI] [PubMed] [Google Scholar]
  4. Bianchi S., Bigazzi R., Quiñones Galvan A., Muscelli E., Baldari G., Pecori N., Ciociaro D., Ferrannini E., Natali A. Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension. 1995 Nov;26(5):789–795. doi: 10.1161/01.hyp.26.5.789. [DOI] [PubMed] [Google Scholar]
  5. Birnbaum M. J. Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell. 1989 Apr 21;57(2):305–315. doi: 10.1016/0092-8674(89)90968-9. [DOI] [PubMed] [Google Scholar]
  6. Boden G., Chen X., Ruiz J., White J. V., Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 1994 Jun;93(6):2438–2446. doi: 10.1172/JCI117252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bonadonna R. C., Del Prato S., Bonora E., Saccomani M. P., Gulli G., Natali A., Frascerra S., Pecori N., Ferrannini E., Bier D. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes. 1996 Jul;45(7):915–925. doi: 10.2337/diab.45.7.915. [DOI] [PubMed] [Google Scholar]
  8. Bonadonna R. C., Del Prato S., Saccomani M. P., Bonora E., Gulli G., Ferrannini E., Bier D., Cobelli C., DeFronzo R. A. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest. 1993 Jul;92(1):486–494. doi: 10.1172/JCI116592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bradley D. C., Poulin R. A., Bergman R. N. Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes. 1993 Feb;42(2):296–306. doi: 10.2337/diab.42.2.296. [DOI] [PubMed] [Google Scholar]
  10. Butler P. C., Kryshak E. J., Marsh M., Rizza R. A. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes. 1990 Nov;39(11):1373–1380. doi: 10.2337/diab.39.11.1373. [DOI] [PubMed] [Google Scholar]
  11. Butler P. C., Kryshak E. J., Schwenk W. F., Haymond M. W., Rizza R. A. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants. Diabetes. 1990 Feb;39(2):217–225. doi: 10.2337/diab.39.2.217. [DOI] [PubMed] [Google Scholar]
  12. Charron M. J., Brosius F. C., 3rd, Alper S. L., Lodish H. F. A glucose transport protein expressed predominately in insulin-responsive tissues. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2535–2539. doi: 10.1073/pnas.86.8.2535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Del Prato S., Bonadonna R. C., Bonora E., Gulli G., Solini A., Shank M., DeFronzo R. A. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest. 1993 Feb;91(2):484–494. doi: 10.1172/JCI116226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dimitrakoudis D., Ramlal T., Rastogi S., Vranic M., Klip A. Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle. Biochem J. 1992 Jun 1;284(Pt 2):341–348. doi: 10.1042/bj2840341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Eriksson J., Koranyi L., Bourey R., Schalin-Jäntti C., Widén E., Mueckler M., Permutt A. M., Groop L. C. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle. Diabetologia. 1992 Feb;35(2):143–147. doi: 10.1007/BF00402546. [DOI] [PubMed] [Google Scholar]
  16. Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M. A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987 Aug 6;317(6):350–357. doi: 10.1056/NEJM198708063170605. [DOI] [PubMed] [Google Scholar]
  17. Giacca A., Fisher S. J., Shi Z. Q., Gupta R., Lickley H. L., Vranic M. Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest. 1992 Nov;90(5):1769–1777. doi: 10.1172/JCI116051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Giaccari A., Rossetti L. Isocratic high-performance liquid chromatographic determination of the concentration and specific radioactivity of phosphoenolpyruvate and uridine diphosphate glucose in tissue extracts. J Chromatogr. 1989 Dec 29;497:69–78. doi: 10.1016/0378-4347(89)80006-4. [DOI] [PubMed] [Google Scholar]
  19. Giaccari A., Rossetti L. Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats. J Clin Invest. 1992 Jan;89(1):36–45. doi: 10.1172/JCI115583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gibbs E. M., Stock J. L., McCoid S. C., Stukenbrok H. A., Pessin J. E., Stevenson R. W., Milici A. J., McNeish J. D. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest. 1995 Apr;95(4):1512–1518. doi: 10.1172/JCI117823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Groop L. C., Bonadonna R. C., DelPrato S., Ratheiser K., Zyck K., Ferrannini E., DeFronzo R. A. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest. 1989 Jul;84(1):205–213. doi: 10.1172/JCI114142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gulli G., Ferrannini E., Stern M., Haffner S., DeFronzo R. A. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes. 1992 Dec;41(12):1575–1586. doi: 10.2337/diab.41.12.1575. [DOI] [PubMed] [Google Scholar]
  23. Hansen P. A., Gulve E. A., Marshall B. A., Gao J., Pessin J. E., Holloszy J. O., Mueckler M. Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter. J Biol Chem. 1995 Jan 27;270(4):1679–1684. doi: 10.1074/jbc.270.5.1679. [DOI] [PubMed] [Google Scholar]
  24. Hollenbeck C., Reaven G. M. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab. 1987 Jun;64(6):1169–1173. doi: 10.1210/jcem-64-6-1169. [DOI] [PubMed] [Google Scholar]
  25. Kahn B. B. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes. 1996 Nov;45(11):1644–1654. doi: 10.2337/diab.45.11.1644. [DOI] [PubMed] [Google Scholar]
  26. Kahn B. B., Rossetti L., Lodish H. F., Charron M. J. Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J Clin Invest. 1991 Jun;87(6):2197–2206. doi: 10.1172/JCI115254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kahn B. B., Shulman G. I., DeFronzo R. A., Cushman S. W., Rossetti L. Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J Clin Invest. 1991 Feb;87(2):561–570. doi: 10.1172/JCI115031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Katz E. B., Stenbit A. E., Hatton K., DePinho R., Charron M. J. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature. 1995 Sep 14;377(6545):151–155. doi: 10.1038/377151a0. [DOI] [PubMed] [Google Scholar]
  29. Koranyi L. I., Bourey R. E., Vuorinen-Markkola H., Koivisto V. A., Mueckler M., Permutt M. A., Yki-Järvinen H. Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man. Diabetologia. 1991 Oct;34(10):763–765. doi: 10.1007/BF00401526. [DOI] [PubMed] [Google Scholar]
  30. Kraegen E. W., James D. E., Jenkins A. B., Chisholm D. J. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol. 1985 Mar;248(3 Pt 1):E353–E362. doi: 10.1152/ajpendo.1985.248.3.E353. [DOI] [PubMed] [Google Scholar]
  31. Kusari J., Verma U. S., Buse J. B., Henry R. R., Olefsky J. M. Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin Invest. 1991 Oct;88(4):1323–1330. doi: 10.1172/JCI115437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Leturque A., Loizeau M., Vaulont S., Salminen M., Girard J. Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes. 1996 Jan;45(1):23–27. doi: 10.2337/diab.45.1.23. [DOI] [PubMed] [Google Scholar]
  33. Lewis G. F., Zinman B., Groenewoud Y., Vranic M., Giacca A. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes. 1996 Apr;45(4):454–462. doi: 10.2337/diab.45.4.454. [DOI] [PubMed] [Google Scholar]
  34. Marette A., Burdett E., Douen A., Vranic M., Klip A. Insulin induces the translocation of GLUT4 from a unique intracellular organelle to transverse tubules in rat skeletal muscle. Diabetes. 1992 Dec;41(12):1562–1569. doi: 10.2337/diab.41.12.1562. [DOI] [PubMed] [Google Scholar]
  35. Marshall B. A., Ren J. M., Johnson D. W., Gibbs E. M., Lillquist J. S., Soeller W. C., Holloszy J. O., Mueckler M. Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle. J Biol Chem. 1993 Sep 5;268(25):18442–18445. [PubMed] [Google Scholar]
  36. Massillon D., Chen W., Hawkins M., Liu R., Barzilai N., Rossetti L. Quantitation of hepatic glucose fluxes and pathways of hepatic glycogen synthesis in conscious mice. Am J Physiol. 1995 Dec;269(6 Pt 1):E1037–E1043. doi: 10.1152/ajpendo.1995.269.6.E1037. [DOI] [PubMed] [Google Scholar]
  37. Mueckler M. Facilitative glucose transporters. Eur J Biochem. 1994 Feb 1;219(3):713–725. doi: 10.1111/j.1432-1033.1994.tb18550.x. [DOI] [PubMed] [Google Scholar]
  38. Mueckler M., Kruse M., Strube M., Riggs A. C., Chiu K. C., Permutt M. A. A mutation in the Glut2 glucose transporter gene of a diabetic patient abolishes transport activity. J Biol Chem. 1994 Jul 8;269(27):17765–17767. [PubMed] [Google Scholar]
  39. Pedersen O., Bak J. F., Andersen P. H., Lund S., Moller D. E., Flier J. S., Kahn B. B. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes. 1990 Jul;39(7):865–870. doi: 10.2337/diab.39.7.865. [DOI] [PubMed] [Google Scholar]
  40. Price T. B., Perseghin G., Duleba A., Chen W., Chase J., Rothman D. L., Shulman R. G., Shulman G. I. NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5329–5334. doi: 10.1073/pnas.93.11.5329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rebrin K., Steil G. M., Getty L., Bergman R. N. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 1995 Sep;44(9):1038–1045. doi: 10.2337/diab.44.9.1038. [DOI] [PubMed] [Google Scholar]
  42. Rebrin K., Steil G. M., Mittelman S. D., Bergman R. N. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest. 1996 Aug 1;98(3):741–749. doi: 10.1172/JCI118846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ren J. M., Marshall B. A., Gulve E. A., Gao J., Johnson D. W., Holloszy J. O., Mueckler M. Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem. 1993 Aug 5;268(22):16113–16115. [PubMed] [Google Scholar]
  44. Ren J. M., Marshall B. A., Mueckler M. M., McCaleb M., Amatruda J. M., Shulman G. I. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest. 1995 Jan;95(1):429–432. doi: 10.1172/JCI117673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Roden M., Price T. B., Perseghin G., Petersen K. F., Rothman D. L., Cline G. W., Shulman G. I. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996 Jun 15;97(12):2859–2865. doi: 10.1172/JCI118742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rossetti L., Barzilai N., Chen W., Harris T., Yang D., Rogler C. E. Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J Biol Chem. 1996 Jan 5;271(1):203–208. doi: 10.1074/jbc.271.1.203. [DOI] [PubMed] [Google Scholar]
  47. Rossetti L., Giaccari A., Barzilai N., Howard K., Sebel G., Hu M. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. J Clin Invest. 1993 Sep;92(3):1126–1134. doi: 10.1172/JCI116681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Rossetti L., Giaccari A. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest. 1990 Jun;85(6):1785–1792. doi: 10.1172/JCI114636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Rossetti L., Hu M. Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production. J Clin Invest. 1993 Dec;92(6):2963–2974. doi: 10.1172/JCI116919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Rossetti L., Lauglin M. R. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest. 1989 Sep;84(3):892–899. doi: 10.1172/JCI114250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Rossetti L., Smith D., Shulman G. I., Papachristou D., DeFronzo R. A. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest. 1987 May;79(5):1510–1515. doi: 10.1172/JCI112981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Rothman D. L., Magnusson I., Cline G., Gerard D., Kahn C. R., Shulman R. G., Shulman G. I. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):983–987. doi: 10.1073/pnas.92.4.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Rothman D. L., Shulman R. G., Shulman G. I. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest. 1992 Apr;89(4):1069–1075. doi: 10.1172/JCI115686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Schalin-Jäntti C., Yki-Järvinen H., Koranyi L., Bourey R., Lindström J., Nikula-Ijäs P., Franssila-Kallunki A., Groop L. C. Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives. Diabetologia. 1994 Apr;37(4):401–407. doi: 10.1007/BF00408478. [DOI] [PubMed] [Google Scholar]
  55. Shepherd P. R., Gnudi L., Tozzo E., Yang H., Leach F., Kahn B. B. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem. 1993 Oct 25;268(30):22243–22246. [PubMed] [Google Scholar]
  56. Shulman G. I., Rothman D. L., Jue T., Stein P., DeFronzo R. A., Shulman R. G. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 1990 Jan 25;322(4):223–228. doi: 10.1056/NEJM199001253220403. [DOI] [PubMed] [Google Scholar]
  57. Stenbit A. E., Burcelin R., Katz E. B., Tsao T. S., Gautier N., Charron M. J., Le Marchand-Brustel Y. Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle. J Clin Invest. 1996 Aug 1;98(3):629–634. doi: 10.1172/JCI118833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Thorburn A. W., Gumbiner B., Bulacan F., Brechtel G., Henry R. R. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest. 1991 Feb;87(2):489–495. doi: 10.1172/JCI115022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Thorburn A. W., Gumbiner B., Bulacan F., Wallace P., Henry R. R. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest. 1990 Feb;85(2):522–529. doi: 10.1172/JCI114468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Treadway J. L., Hargrove D. M., Nardone N. A., McPherson R. K., Russo J. F., Milici A. J., Stukenbrok H. A., Gibbs E. M., Stevenson R. W., Pessin J. E. Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. J Biol Chem. 1994 Nov 25;269(47):29956–29961. [PubMed] [Google Scholar]
  61. Tsao T. S., Burcelin R., Katz E. B., Huang L., Charron M. J. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes. 1996 Jan;45(1):28–36. doi: 10.2337/diab.45.1.28. [DOI] [PubMed] [Google Scholar]
  62. Turk D., Alzaid A., Dinneen S., Nair K. S., Rizza R. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest. 1995 Feb;95(2):755–762. doi: 10.1172/JCI117723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Vaag A., Alford F., Henriksen F. L., Christopher M., Beck-Nielsen H. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia. 1995 Mar;38(3):326–336. doi: 10.1007/BF00400638. [DOI] [PubMed] [Google Scholar]
  64. Vaag A., Damsbo P., Hother-Nielsen O., Beck-Nielsen H. Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992 Jan;35(1):80–88. doi: 10.1007/BF00400856. [DOI] [PubMed] [Google Scholar]
  65. Vaag A., Henriksen J. E., Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1992 Mar;89(3):782–788. doi: 10.1172/JCI115656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Vaag A., Henriksen J. E., Madsbad S., Holm N., Beck-Nielsen H. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest. 1995 Feb;95(2):690–698. doi: 10.1172/JCI117715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Wang W., Hansen P. A., Marshall B. A., Holloszy J. O., Mueckler M. Insulin unmasks a COOH-terminal Glut4 epitope and increases glucose transport across T-tubules in skeletal muscle. J Cell Biol. 1996 Oct;135(2):415–430. doi: 10.1083/jcb.135.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Waters S. B., Yamauchi K., Pessin J. E. Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signaling. J Biol Chem. 1993 Oct 25;268(30):22231–22234. [PubMed] [Google Scholar]
  69. Zierath J. R., Houseknecht K. L., Gnudi L., Kahn B. B. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes. 1997 Feb;46(2):215–223. doi: 10.2337/diab.46.2.215. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES